Trials / Sponsors / Mimetogen Pharmaceuticals USA, Inc.
Mimetogen Pharmaceuticals USA, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye Dry Eye Syndromes, Dry Eye Disease, Kerato Conjunctivitis Sicca | Phase 3 | 2023-06-28 |
| Completed | Tavilermide Ophthalmic Solution for the Treatment of Dry Eye Keratoconjunctivitis Sicca, Dry Eye | Phase 3 | 2019-03-28 |
| Completed | A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease Keratoconjunctivitis Sicca | Phase 3 | 2016-01-01 |
| Completed | A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Keratoconjunctivitis Sicca | Phase 3 | 2015-12-01 |
| Completed | A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye Dry Eye Syndromes | Phase 3 | 2013-10-01 |
| Completed | Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye Dry Eye | Phase 2 | 2010-11-01 |